New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
05:53 EDTBBRY, AZNStocks with implied volatility movement; AZN BBRY
Stocks with implied volatility movement; AstraZeneca (AZN) 44, BlackBerry (BBRY) 53 according to iVolatility.
News For AZN;BBRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 21, 2015
07:37 EDTAZNPfizer replaces AbbVie as top global pharma pick at Jefferies
Subscribe for More Information
May 20, 2015
11:51 EDTAZNExpress Scripts' Medco to pay $7.9M to resolve kickback allegations
Medco Health Solutions, a wholly-owned subsidiary of the pharmacy benefit manager Express Scripts Holding Company (ESRX), of Missouri, has agreed to pay the government $7.9M to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced. Medco provides pharmacy benefit management services to clients who receive subsidies under the Medicare Retiree Drug Subsidy program. The settlement resolves allegations that Medco solicited remuneration from AstraZeneca, a pharmaceutical manufacturer, in exchange for identifying Nexium as the “sole and exclusive” proton pump inhibitor on certain of Medco’s prescription drug lists known as formularies. The United States alleged that Medco received some or all of the remuneration from AstraZeneca in the form of reduced prices on the following AstraZeneca drugs: Prilosec, Toprol XL and Plendil. The United States contended that this kickback arrangement between Medco and AstraZeneca (AZN) violated the Federal Anti-Kickback statute, and thereby caused the submission of false or fraudulent claims for Nexium to the Retiree Drug Subsidy Program. In January 2015, the United States and AstraZeneca reached a $7.9M settlement to resolve kickback allegations arising out of the same conduct. This civil settlement resolves a lawsuit filed under the qui tam, or whistleblower, provision of the False Claims Act, which allows private citizens with knowledge of false claims to bring civil actions on behalf of the government and to share in any recovery. The lawsuit was filed by former AstraZeneca employees Paul DiMattia and F. Folger Tuggle, whose share of the settlement has not been determined. The settlement with Medco was the result of a coordinated effort among the Civil Division, the U.S. Attorney’s Office of the District of Delaware and HHS-OIG.
May 19, 2015
15:05 EDTAZNArdelyx scheduled for end Phase 2 meeting with FDA scheduled in June
Subscribe for More Information
08:37 EDTBBRYBlackBerry software showing encouraging signs, says RBC Capital
RBC Capital says it's seeing encouraging signs regarding the sales of BlackBerry's software to regulated sectors, including government ,financials, and healthcare. The firm says that the company's mobile device management system, BES 12, is adding customers, while its resellers are getting more comfortable selling its software and sales of its technology solutions products are beating its guidance. RBC slashed its hardware sales estimates for the company and expects its Q1 revenue to come in well below expectations as a result, but adds that software has become the company's focus. It keeps an $11 price target and Sector Perform rating on the shares.
06:29 EDTBBRYBlackBerry CEO says smartphone business will be profitable again, BI reports
Subscribe for More Information
May 18, 2015
06:13 EDTAZNAstraZeneca to invest $285M in new biologics manufacturing facility in Sweden
AstraZeneca announced that it plans to invest approximately $285M in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that the new facility will supply medicines for clinical trial programs of AstraZeneca and MedImmune, the company’s global biologics research and development arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019. Södertälje is currently home to AstraZeneca’s largest global tablets and capsules manufacturing facility and is also a launch platform site for the company, with specialist capabilities on-site that allow large-scale production of new medicines, working closely with the research and development organisation. By locating the new manufacturing plant in Södertälje, the company will combine its expertise in biologics with the well-established culture of operational excellence that exists within the Sweden Operations unit. The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019. The new manufacturing facility in Sweden will support the progression of drug candidates across the main therapy areas and be aligned with investments being made in the current biologics manufacturing centers, such as the expansion in Frederick, Maryland, announced in November.
05:50 EDTBBRYStocks with implied volatility movement; BBRY MNKD
Stocks with implied volatility movement; BlackBerry (BBRY) 55, MannKind (MNKD) 75 according to iVolatility.
May 17, 2015
15:49 EDTAZNAstraZeneca reports Movantik shows 'similar' adverse event rate vs. placebo
Subscribe for More Information
May 15, 2015
15:26 EDTBBRYBlackBerry calls active amid rumor of Microsoft investigation of potential bid
Subscribe for More Information
15:00 EDTBBRYBlackBerry rises amid rumor of Microsoft investigation of potential bid
Shares of BlackBerry (BBRY) are higher in afternoon trading after Ben Harrington's Betaville blog said Microsoft (MSFT) is said to have requested Deutsche Bank (DB) and Goldman Sachs (GS) examine whether the company should acquire the mobile device maker. His source said Microsoft has not yet approached Blackberry and is still in the "very early stages" of looking into making a potential deal, Harrington added. BlackBerry is up 1.7% to $10.50 following the blog post. Reference Link
14:54 EDTBBRYMicrosoft said to examine potential for BlackBerry bid, Betaville says
Subscribe for More Information
10:34 EDTBBRYOptions with increasing implied volatility
Subscribe for More Information
09:31 EDTAZNAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
May 14, 2015
09:22 EDTAZNLeerink pharma/biotech analysts hold an analyst/industry conference call
Subscribe for More Information
05:52 EDTAZNMizuho expects CAR T stocks to be volatile after ASCO abstract
Subscribe for More Information
May 13, 2015
17:24 EDTAZNAstraZeneca to update progress with immuno-oncology pipeline at ASCO
AstraZeneca and MedImmune, the company’s global biologics research and development arm, will demonstrate rapid progress with their combination-focused oncology pipeline at the American Society of Clinical Oncology, or ASCO, Annual Meeting, May 29-June 2. 61 scientific abstracts will be presented at the meeting, reinforcing the significant progress in immuno-oncology through combination therapies and innovative companion diagnostics.
13:15 EDTBBRYInquirer discusses recent Apple for BlackBerry takeover rumors
Subscribe for More Information
May 12, 2015
05:58 EDTBBRYStocks with implied volatility movement; MNKD BBRY
Subscribe for More Information
May 11, 2015
10:18 EDTBBRYBlackBerry calls active on renewed takeover chatter
Blackberry May calls are active 13K contracts (1K puts) on renewed takeover speculation. May call option implied volatility is at 39, June is at 58, August is at 44; compared to its 90-day average of 48 according to Track Data. Active call volume suggests traders taking positions for large near term price movement.
10:11 EDTBBRYRumor: BlackBerry moves up on renewed takeover chatter
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use